Home > Insider Trading > Filing (0001562180-20-005510)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780980	D. Daniel Burton	C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-08-14	61,190	$10.30	243,129	No	4	M	Direct
Common Stock	Disposition	2020-08-14	61,190	$31.41	181,939	No	4	S	Direct
Common Stock	Acquisiton	2020-08-17	15,235	$6.24	197,174	No	4	M	Direct
Common Stock	Acquisiton	2020-08-17	67,934	$10.80	265,108	No	4	M	Direct
Common Stock	Acquisiton	2020-08-17	27,253	$10.30	292,361	No	4	M	Direct
Common Stock	Disposition	2020-08-17	72,937	$32.05	219,424	No	4	S	Direct
Common Stock	Disposition	2020-08-17	37,485	$32.05	181,939	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-14	61,190	$0.00	61,190	$10.30
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	67,934	$0.00	67,934	$10.80
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	27,253	$0.00	27,253	$10.30
Common Stock	Stock Option (Right to Buy)	Disposition	2020-08-17	15,235	$0.00	15,235	$6.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
27,253	2019-12-17	2025-12-17	No	4	M	Direct
679,289		2028-09-27	No	4	M	Direct
0	2019-12-17	2025-12-17	No	4	M	Direct
20	2018-05-13	2024-06-12	No	4	M	Direct

Footnotes

The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $32.05 to $32.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.05 to $32.04, inclusive.
25% of the 261,166 shares underlying the options vested in an annual installment on December 17, 2016 and the remaining balance vested in equal monthly installments until the option vested in full on December 17, 2019.
25% of the 747,223 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
25% of the 76,465 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested in equal monthly installments until the option vested in full on May 13, 2018.